Elite in Arthritis

David A. Walsh-Andrew

5th Floor, Meridian Court, 5 Cadogan Street, 
Glasgow, SCT, GB 
Elite in Arthritis
5th Floor, Meridian Court, 5 Cadogan Street, 
Glasgow, SCT, GB 
OverviewLocationsClinical Research

Overview

David Walsh-Andrew practices in Glasgow, United Kingdom. Mr. Walsh-Andrew is rated as an Elite expert by MediFind in the treatment of Arthritis. His top areas of expertise are Arthritis, Osteoarthritis, Synovitis, Rheumatoid Arthritis (RA), and Knee Replacement.

His clinical research consists of co-authoring 302 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 141 articles and participated in 4 clinical trials in the study of Arthritis.

Gender
Male

Locations

5th Floor, Meridian Court, 5 Cadogan Street, Glasgow, SCT, United Kingdom
Other Locations
Hucknall Road, Nottingham, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomised Controlled Trial of Job Retention Vocational Rehabilitation for Employed People With Inflammatory Arthritis: the WORKWELL Trial.
A Randomised Controlled Trial of Job Retention Vocational Rehabilitation for Employed People With Inflammatory Arthritis: the WORKWELL Trial.
Enrollment Status: Completed
Publish Date: April 01, 2025
Intervention Type: Other
Study Phase: Not Applicable
Central Aspects of Pain in Rheumatoid Arthritis
Central Aspects of Pain in Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: December 05, 2023
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
View 3 Less Clinical Trials

302 Total Publications

Isolation of Marine Bacteria through a "Bait" Approach.
Isolation of Marine Bacteria through a "Bait" Approach.
Journal: Canadian journal of microbiology
Published: November 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Walsh-Andrew's expertise for a condition
ConditionClose
View All 10 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile